Commit To Buy BioCryst Pharmaceuticals At $7, Earn 12.9% Using Options
Investors eyeing a purchase of BioCryst Pharmaceuticals Inc (Symbol: BCRX) shares, but cautious about paying the going market price of $8.49/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in pa
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-476209896-bb370633639c479491f738b1991c53fc.jpg "Can Undocumented Immigrants Collect Social Security?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1503239849-0dc8617d35594774b51c998694997431.jpg "How to Spot Key Stock Chart Patterns")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2160638126-8586baebb75d45948df003ed6d451a7e.jpg "What Would a Dollar Crisis Mean for Your Wallet?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-2151482893-a40bcb530bad4c1e9fc4543ca9cdb5f7.jpg "<div>Want to Retire in 2025? Here Are 6 Things I'm Telling My Clients</div>")
:max_bytes(150000):strip_icc():format(jpeg)/NYSE-glass-flkr-56a02ca23df78cafdaa06a86.jpg "Which Days Are the U.S. Stock Exchanges Closed?")
:max_bytes(150000):strip_icc():format(jpeg)/GettyImages-1125671887-f41de5ad85f4477c8adb9f11b1261ba6.jpg "Put-Call Ratio Meaning and How To Use It To Gauge Market Sentiment")